Compare AbCellera Biologics Inc (ABCL) vs Futu Holdings Ltd (FUTU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Futu Holdings Ltd — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Futu Holdings Ltd trades at $95.48 (market cap $13.19B). The key difference: Futu Holdings Ltd is far larger — about 5.6× AbCellera Biologics Inc's market cap, and Futu Holdings Ltd pays a 2.76% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | FUTU | |
|---|---|---|
Market Cap | $2.35B | $13.19B |
Sector | Health | Financials |
52-Week High | $8.12 | $199.04 |
52-Week Low | $2.78 | $89.76 |
Enterprise Value | $1.99B | $13.04B |
Dividend Yield | — | 2.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Futu Holdings Ltd
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →
